Overview
Adolescence is a critical period of neurobiological, physical, psychological, social, and cognitive transformation bridging childhood and adulthood. For the psychiatrist, mastery of normal adolescent development is essential for:
- Distinguishing normative developmental phenomena from emerging psychopathology
- Delivering developmentally calibrated clinical assessments
- Formulating appropriate, stage-specific interventions
- Adolescence broadly begins with puberty and concludes with attainment of adult social, occupational, and psychological roles.
- No single biological or psychosocial marker precisely delineates its boundaries.
- Chronological age (roughly 10-24 years) is a poor proxy; developmental stage, cultural context, and individual variation all modulate the trajectory.
Epidemiology
- Approximately 20% of adolescents in Western settings have clinically significant psychological disturbance warranting intervention.
- Conversely, survey research (Offer et al.) demonstrates that approximately 80% of adolescents do not experience severe turmoil, relate well to family and peers, and transition to adulthood without major disruption, challenging the assumption that disturbance is inherent to adolescence.
- Major psychiatric disorders peaking in onset during adolescence or early adulthood: depressive disorders, anxiety disorders, schizophrenia spectrum disorders, eating disorders, and substance use disorders.
- Suicide is the second leading cause of death in young people aged 10-24 (CDC data).
Biological and Pubertal Development
Physical Changes
Puberty is initiated by activation of the hypothalamic-pituitary-gonadal (HPG) axis. Secondary sexual characteristics are staged using the Sexual Maturity Rating (SMR) system (synonymous with Tanner Stages, SMR 1-5):
- SMR 1: Prepubertal, no sexual development
- SMR 2-4: Progressive pubertal development
- SMR 5: Fully mature secondary sexual characteristics
- SMR in females is based on breast development and pubic hair; in males on testicular/penile development and pubic hair.
- SMR correlates with, but is independent of, chronological age.
| Parameter | Females | Males |
|---|---|---|
| Body fat change | 16% → 27% by end of adolescence; lean mass falls 80% → 75% | Body fat decreases to ~12% by end of puberty |
| Weight gain (mean) | 17.5 kg (range 7-25 kg) | 23.7 kg (range 7-30 kg) |
| Peak weight gain after linear growth spurt | 3-6 months | ~3 months |
| 90% adult skeletal mass accrued by | Age 16 | Age 18 |
| Duration of puberty (average) | ~4 years | ~3 years (range 2-5 years) |
Pubertal weight gain accounts for approximately half of ideal adult body weight.
Neurodevelopment
The adolescent brain undergoes profound structural and functional reorganisation. Key concepts:
Dual System Model
The Dual System Model describes a developmental mismatch between:
- Social-emotional reactivity system (subcortical/limbic; amygdala-centred), matures earlier
- Cognitive control system (prefrontal cortex), continues maturing into mid-twenties
This mismatch underpins the increased risk-taking, sensation-seeking, and emotional reactivity characteristic of mid-adolescence (Strang, Chein & Steinberg, 2013).
Neuroimaging Findings
- Synaptic pruning and myelination are most active in the prefrontal and parietal cortex, supporting gradual maturation of executive function, planning, and impulse control.
- Functional MRI: heightened amygdala reactivity to social/emotional stimuli; diminished amygdala with increased dorsolateral PFC activation in female adolescents, suggesting earlier emotional regulatory maturity in females.
- Puberty is a period of synaptic reorganisation placing the brain in a sensitised state for development of executive functions and social cognitive skills.
- Mentalising networks become increasingly active during adolescence, supporting enhanced theory of mind and social cognition (Blakemore & Mills, 2014).
Striking Features of Adolescent Social-Emotional Development
Five cardinal features (supported by neuroimaging and developmental research):
- Increased peer group affiliation
- Striving for autonomy from parents
- Increasing capacity to mentalise (understand others' thoughts and feelings)
- Increased risk-taking behaviour
- Greater sensation-seeking
Phases of Adolescent Development
| Phase | Approximate Age | Key Developmental Features |
|---|---|---|
| Early | 10-13 years | Pubertal onset; body image preoccupation; concrete thinking; peer conformity begins; separation from parents initiated; body image vulnerability greatest |
| Middle | 14-16 years | Peak risk-taking and sensation-seeking; intense peer affiliation; abstract thinking develops; identity exploration; romantic/sexual relationships begin; enforced dependency from illness is most disruptive |
| Late | 17-21+ years | Identity consolidation; more stable relationships; future orientation; autonomy established; educational/vocational concerns predominate; return to family connectedness |
Cognitive Development
Adolescence marks the Piagetian transition from concrete operational to formal operational thinking, enabling:
- Hypothetical-deductive reasoning
- Abstract thought and metacognition
- Consideration of multiple perspectives simultaneously
- Sophisticated moral reasoning and philosophical inquiry
This cognitive maturation underpins emerging capacity for autonomous medical decision-making.
Identity Development
Erikson's psychosocial framework identifies the central adolescent task as Identity vs. Role Confusion.
Marcia's four identity statuses (elaborating Erikson):
| Status | Exploration | Commitment |
|---|---|---|
| Diffusion | Absent | Absent |
| Foreclosure | Absent | Present (adopted without exploration) |
| Moratorium | Active | Absent |
| Achievement | Completed | Present |
Key clinical points:
- Identity development is non-linear; regression is normative, especially under stress.
- The quest for identity generates heightened self-consciousness, vulnerability to shame, and reluctance to disclose distress, directly relevant to clinical engagement.
- Anna Freud observed that maintaining steady equilibrium during adolescence is itself abnormal; however, contemporary evidence (Offer et al.) clarifies that most adolescents do not experience severe turmoil, those who do warrant clinical assessment, not reassurance.
Social and Peer Development
- Early adolescence: dyadic friendships → larger peer group affiliations; popularity-focused
- Mid-adolescence: intense peer affiliation; susceptibility to peer influence on risk-taking (amplified by Dual System immaturity)
- Late adolescence: deeper, more reciprocal friendships; identity no longer dependent on single peer group conformity; romantic relationships
- Increasing mentalising capacity supports social cognition throughout
- Digital media and social platforms: pervasive contemporary influence on identity, body image, peer relationships, and self-esteem; screen for cyberbullying, online exploitation, and harmful content as routine components of assessment
Sexual Development
Sexual interest and experimentation are normative. Typical developmental sequence:
- Fantasy and masturbation (early adolescence)
- Non-penetrative genital activity with partners
- Oral sex
- Initiation of sexual intercourse (later adolescence)
In surveys (YRBSS 2018-2019), 38.4% of high school students reported sexual intercourse; at least one-third of urban adolescents reported some form of partnered genital activity in the prior year; approximately 10% reported oral sexual behaviour with a partner.
Sexual orientation and gender identity are important dimensions requiring sensitive, non-judgemental, and affirming clinical engagement.
Emotional Development: Normative Features
| Feature | Clinical Note |
|---|---|
| Heightened emotional reactivity and mood lability | Contextual and transient; not equivalent to mood disorder |
| Ambivalence about autonomy | Simultaneously seeks independence and parental security |
| Idealism alternating with self-centredness | Described by Anna Freud as normative |
| Personal fable and heightened self-consciousness | Fear of public exposure and shame; drives reluctance to disclose |
| Reluctance to share troubling feelings | Due to self-consciousness/vulnerability, not merely developmental lag |
Assessment
General Principles
- Individualise to developmental stage, not chronological age
- Conduct part of the interview with the adolescent alone to establish confidentiality and rapport
- Observe the adolescent-parent interaction
- Adopt a non-judgemental, culturally sensitive, and affirming stance
- Explore the adolescent's own perspective and the meaning they attach to their difficulties
Consultation Structure
Based on the structured adolescent consultation visit framework (Table 9-2):
| Step | Topics | With Whom |
|---|---|---|
| 1 | Visit structure; history of present illness; past and family history | Adolescent + parent(s) |
| 2 | Parental concerns; preventive guidance; confidentiality introduced | Parent(s) alone |
| 3 | Confidentiality confirmed; history including sexuality and risk behaviours | Adolescent alone |
| 4 | Physical examination (as indicated) | Adolescent (± parent per adolescent's preference) |
| 5 | Findings, recommendations; parental involvement parameters; lab notification plan; preventive guidance | Adolescent |
| 6 | Summary (as appropriate) | Adolescent + parent(s) |
HEEADSSS Psychosocial Assessment
Gold-standard structured psychosocial screening framework for adolescents:
| Domain | Focus Areas |
|---|---|
| H, Home | Living situation, family relationships, safety |
| E, Education/Employment | School performance, engagement, future plans |
| E, Eating | Body image, disordered eating, weight concerns |
| A, Activities | Recreation, exercise, hobbies, screen time |
| D, Drugs | Tobacco, alcohol, cannabis, other substances |
| S, Sexuality | Activity, orientation, gender identity, contraception, STI risk |
| S, Suicide/Depression | Mood, self-harm, suicidal ideation and intent, past attempts |
| S, Safety | Risk behaviours, violence, driving |
Confidentiality
- Confidentiality is essential: when guaranteed, adolescents are more likely to seek care, disclose sensitive information, and trust their clinician; most will involve parents voluntarily under these conditions.
- Limits must be discussed explicitly at the outset with both adolescent and family.
- Confidentiality is overridden when there is: current suicidal or homicidal intent, imminent danger to the adolescent or another person, or mandatory reporting obligations (child abuse).
- Legal definitions vary by jurisdiction; clinicians must know local law.
Indicators of Pathology vs. Normative Development
| Feature | Normal Development | Emerging Psychopathology |
|---|---|---|
| Mood lability | Transient, contextual, resolves | Persistent, pervasive, context-independent |
| Risk-taking | Episodic, peer-influenced | Escalating, solitary, high-lethality |
| Social withdrawal | Shifting peer groups, temporary | Sustained isolation, anhedonia |
| Identity exploration | Active experimentation, flexible | Rigid, highly ego-dystonic |
| Academic decline | Minor, situational | Sustained, progressive |
| Sleep changes | Circadian phase delay (normative) | Severe insomnia/hypersomnia plus other symptoms |
| Irritability | Reactive, resolves | Chronic, severe, with anhedonia |
Key clinical questions when considering whether an adolescent needs intervention:
- Has there been a developmental lapse, a falloff from prior trajectory in school, home, friendships, or activities?
- What is the level of emotional distress and its meaning to the adolescent?
- What is the range of coping skills available?
- What supports does the adolescent have from adults at home or in the community?
- Is there evidence of an emerging psychiatric disorder or positive family history?
- How impulsive is the adolescent? Is there family psychopathology or major family disruption?
- Are there concerns about physical or sexual abuse?
Validated Rating Scales
| Scale | Domain | Notes |
|---|---|---|
| HEEADSSS | Psychosocial screening | Structured interview; not scored; universal use |
| PHQ-A | Depression | 9-item; validated ≥12 years |
| GAD-7 | Anxiety | Validated in adolescent populations |
| CRAFFT | Substance use | Validated adolescent screening tool |
| Columbia Suicide Severity Rating Scale (C-SSRS) | Suicidality | Widely used across age groups |
| Children's Global Assessment Scale (CGAS) | Global functioning | Clinician-rated; 1-100 scale |
Differential Diagnosis
Disorders with important adolescent-onset presentations requiring differentiation from normal development:
- Major depressive disorder
- Bipolar disorder (type I and II)
- Anxiety disorders (social anxiety disorder, GAD, panic disorder)
- Eating disorders (anorexia nervosa, bulimia nervosa, ARFID)
- Emerging personality disorder features, ICD-11 permits personality disorder diagnosis from age 18 with appropriate developmental caveat (not recommended before 18 per ICD-11 guidance); DSM-5-TR notes personality disorder diagnosis in adolescents is possible but should be applied cautiously and only if features have been present for at least 1 year (except ASPD, which requires age ≥18)
- Substance use disorders (DSM-5-TR severity specifiers: mild/moderate/severe)
- Psychotic disorders (schizophrenia, brief psychotic disorder)
- ADHD (often presenting or re-presenting in adolescence with increased executive demands)
- Cannabis use disorder (particularly relevant given prevalence and neurodevelopmental vulnerability)
Management
Engagement and Therapeutic Alliance
Rapport-building is the cornerstone of adolescent psychiatric treatment. Practical strategies:
- Begin by exploring non-clinical topics (friends, hobbies, school) to establish alliance
- Demonstrate sensitivity to developmental stage, sexual orientation, gender identity, and cultural background
- Respect the adolescent's growing need for independence and to be treated as an individual
- Explore the adolescent's perspective before seeking parental input
Consent, Assent, and Legal Framework
- Gillick competence (reflected in Australian common law): adolescents may consent to treatment if they demonstrate sufficient maturity and understanding, a functional, not age-based, assessment
- Assent: even when parental consent is legally required, seeking the adolescent's genuine agreement is ethically important and clinically effective
- Parents must provide informed consent for most treatments in those under 18; exceptions exist (emergency, emancipated minors, jurisdiction-specific provisions)
- Involuntary treatment governed by state/territory Mental Health Acts (e.g. Mental Health Act 2014 [Vic], Mental Health and Wellbeing Act 2022 [Vic], Mental Health Act 2016 [Qld], Mental Health Act 2007 [NSW]) with additional procedural safeguards for minors
- Treatment against an adolescent's will is reserved for extreme circumstances (severe psychosis, dangerous suicidality)
Pharmacological Interventions
Reserved for diagnosed psychiatric conditions, not developmental disturbance per se. Principles:
- Start at lower doses; titrate carefully
- Monitor for adverse effects: suicidality (antidepressants, black box warning; particularly monitor in first weeks), metabolic effects (antipsychotics), growth suppression (stimulants), sexual dysfunction (SSRIs, discuss privately with adolescent)
- Discuss risks and benefits with both adolescent and parent; document assent
| Drug Class | Agent(s) | Indication | Notes |
|---|---|---|---|
| SSRI | Fluoxetine, sertraline | Depression, anxiety | Fluoxetine has strongest adolescent evidence base; TGA/NICE-supported |
| Stimulant | Methylphenidate, mixed amphetamine salts | ADHD | Monitor growth, cardiovascular parameters |
| Atypical antipsychotic | Risperidone, olanzapine, aripiprazole | Psychosis, bipolar disorder | Metabolic monitoring essential |
| Mood stabiliser | Lithium, valproate, lamotrigine | Bipolar disorder | Valproate, teratogenicity counselling in females |
Psychological Interventions
| Intervention | Primary Indication(s) | Evidence Base |
|---|---|---|
| Cognitive Behavioural Therapy (CBT) | Depression, anxiety, eating disorders | Strong; adapt to developmental stage |
| Dialectical Behaviour Therapy, Adolescent (DBT-A) | Emotion dysregulation, self-harm, borderline features | Strong |
| Family-Based Treatment (FBT/Maudsley) | Anorexia nervosa | Preferred first-line for adolescent AN |
| Interpersonal Therapy for Adolescents (IPT-A) | Depression | Evidence-based; targets developmental interpersonal themes |
| Motivational Interviewing (MI) | Substance use, treatment engagement | Effective in adolescent populations |
| Multisystemic Therapy (MST) | Conduct disorder, antisocial behaviour | Integrates home, school, and community; evidence-based |
Social and Systems-Level Interventions
- School liaison: psychoeducation for teachers; classroom adjustments; school wellbeing support; small interventions (e.g. classroom change) can be highly effective
- Family psychoeducation and family therapy
- Community mental health: headspace (Australia), Orygen-affiliated services, Te Pou (NZ)
- Digital/online mental health resources (increasing evidence base)
- Vocational support for older adolescents
Special Populations
Adolescents with Chronic Physical Illness
Chronic illness disrupts normal developmental tasks differentially by phase:
| Phase | Key Developmental Challenge |
|---|---|
| Early adolescence | Distorted body image; isolation from peers |
| Middle adolescence | Enforced dependency; decreased peer acceptance |
| Late adolescence | Educational/vocational impairment; concerns about relationships, marriage, and future |
Management principles:
- Treat the "adolescent with [condition]", not the condition as the adolescent's defining identity
- Encourage self-care autonomy and self-reliance
- Minimise unnecessary medical intrusiveness and procedures
- Provide honest, understandable information; acknowledge uncertainty without withholding prognosis
- Address parental overprotectiveness; avoid conspiracy of silence with dying adolescents
- The more visible a condition, paradoxically, the less the psychological suffering; invisible conditions (e.g. epilepsy) carry greater stigma burden
- Fluctuating/unpredictable illness course is more distressing than stable or predictable trajectories
Gender and Sexually Diverse Adolescents
- LGBTQIA+ adolescents experience elevated rates of depression, anxiety, self-harm, and suicidality, primarily attributable to minority stress, family rejection, and social stigma.
- Clinical assessment must be affirming, non-judgemental, and consistent with RANZCP Position Statements on LGBTQIA+ mental health.
First Nations Adolescents (Australia and New Zealand)
- Aboriginal, Torres Strait Islander, and Māori adolescents require culturally safe, community-informed, and trauma-informed approaches.
- The profound developmental impacts of historical trauma, systemic racism, housing instability, and community disruption must be explicitly recognised.
- Refer to RANZCP Position Statements on Indigenous mental health and, in NZ, Te Tiriti o Waitangi obligations.
Prognosis
- Most adolescents navigate the developmental period successfully without lasting psychological morbidity.
- Early identification and appropriate intervention substantially improve outcomes for those with emerging mental illness.
| Protective Factors | Risk Factors |
|---|---|
| Strong family relationships | History of trauma or abuse |
| Supportive peer networks | Family psychopathology |
| Academic engagement | Substance use |
| Good coping repertoire | Diagnosable psychiatric disorder |
| Community connectedness | Social isolation, bullying, cyberbullying |
| Cultural identity and belonging | Minority stress (LGBTQIA+, First Nations) |
High-Yield Examination Summary
- 80% of adolescents do not experience severe turmoil; 20% require clinical intervention
- SMR (Tanner Stages) 1-5; SMR is independent of chronological age
- Dual System Model: limbic > prefrontal maturation → risk-taking, emotional reactivity
- HEEADSSS: H-E-E-A-D-S-S-S (Home, Education, Eating, Activities, Drugs, Sexuality, Suicide/Depression, Safety)
- Erikson: Identity vs. Role Confusion; Marcia: diffusion/foreclosure/moratorium/achievement
- Confidentiality is overridden by suicidal/homicidal intent, imminent danger, mandatory reporting
- Gillick competence: functional capacity assessment, not age-based
- Fluoxetine: strongest adolescent antidepressant evidence; black box warning for suicidality applies to all antidepressants in under-25s
- MST: evidence-based for conduct disorder; integrates school, home, community, office
- DBT-A: evidence-based for adolescent emotion dysregulation and self-harm
- FBT (Maudsley): preferred first-line for adolescent anorexia nervosa
- Suicide: second leading cause of death in adolescents aged 10-24